Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 4/20 | 0.56 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.56 |
| ▸ | NPY1R | P25929 | 1/20 | 0.55 |
| ▸ | NPY2R | P49146 | 1/20 | 0.55 |
| ▸ | NPY4R | P50391 | 1/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Laminin SCHEMBL29359946 | 1.00 | NTSR1 (0.56) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL29502171 | 0.92 | QRFPR (0.57) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL29671012 | 0.90 | NTSR1 (0.54) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL29472190 | 0.89 | OPRD1 (0.54) | NTSR1NTSR2OPRD1OPRM1OPRK1 | |
| Laminin SCHEMBL2182807 | 0.88 | OPRD1 (0.55) | NPY1RNPY2RNPY4ROPRD1OPRM1 | |
| Laminin SCHEMBL2182800 | 0.88 | OPRD1 (0.55) | NPY1RNPY2RNPY4ROPRD1OPRM1 | |
| SCHEMBL31756855 | 0.87 | NTSR1 (0.66) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL29472198 | 0.86 | OPRD1 (0.58) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30887562 | 0.85 | OPRD1 (0.64) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29418259 | 0.83 | NPY1R (0.57) | NPY1RNPY2RNPY4ROPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636476-B2 | Method of implantation of cell aggregates and tissue fragments | NEURONANO AB (SE) | 2026-05-26 | — | — | US | claimed |
| CN-122081212-A | Molecular self-assembled integrin patch for regulating and controlling cell mechanical signals, and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122056786-A | Lipid hybridization nanoparticle and preparation method and application thereof | 上海世领制药有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4739698-A1 | SELF-HEALING ANTI-MICROBIAL PEPTIDE HYDROGELATORS | NewSouth Innovations Pty Limited (AU) | 2026-05-13 | — | — | EP | claimed |
| US-12589188-B2 | Hydrogels for in situ-forming tissue constructs | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-03-31 | — | — | US | claimed |
| EP-4687476-A1 | HOLLOW FIBRES | IP Ventures GmbH (CH) | 2026-02-11 | — | — | EP | claimed |
| EP-3971201-B1 | CELL CULTURING SCAFFOLD MATERIAL AND CELL CULTURING CONTAINER | SEKISUI CHEMICAL CO LTD (JP) | 2026-01-28 | — | — | EP | claimed |
| EP-3971200-B1 | CELL CULTURING SCAFFOLDING MATERIAL AND CELL CULTURING VESSEL | SEKISUI CHEMICAL CO LTD (JP) | 2026-01-21 | — | — | EP | claimed |
| US-20250368950-A1 | SCAFFOLD MATERIAL FOR CELL CULTURE | SEKISUI CHEMICAL CO., LTD. (JP) | 2025-12-04 | — | — | US | claimed |
| EP-4649308-A2 | APTAMER-BASED ANALYTE MONITORING SYSTEM | Biolinq, Inc. (US) | 2025-11-19 | — | — | EP | claimed |
| CN-114269391-A | Hydrogel inclusion complexes comprising physiologically active substances bound to thermosensitive poly (phosphazene) through host-guest interactions using beta-cyclodextrin and uses thereof | 韩国科学技术研究院 | 2022-04-01 | — | — | CN | claimed |
| CN-114225115-A | Nondestructive modified blood vessel substitute containing living cells and preparation method thereof | 南开大学 | 2022-03-25 | — | — | CN | claimed |
| CN-114225121-A | Endothelialization part absorbable anti-adhesion fibrous membrane and preparation method thereof | 无锡中科光远生物材料有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-114177363-A | Anti-adhesion fiber membrane for promoting endothelialization and preparation method thereof | 无锡中科光远生物材料有限公司 | 2022-03-15 | — | — | CN | claimed |
| CN-114177369-A | Blocking anti-adhesion membrane material and preparation method thereof | 无锡中科光远生物材料有限公司 | 2022-03-15 | — | — | CN | claimed |
| US-11261263-B2 | Protein coated polymeric substrate | PORVAIR SCIENCES LIMITED (GB) | 2022-03-01 | — | — | US | claimed |
| EP-3955967-A1 | PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES | Aadigen, LLC (US) | 2022-02-23 | — | — | EP | claimed |
| WO-2022035783-A2 | TOPICAL AND PARENTERAL USE AND ADMINISTRATION OF SELF-ASSEMBLING AMPHIPHILIC PEPTIDE HYDROGELS | GEL4MED, INC. (US) | 2022-02-17 | — | — | WO | claimed |
| EP-3575391-B1 | HYDROGELS FOR CULTIVATING PANCREATIC ORGANOIDS | CELLENDES GMBH (DE) | 2022-02-16 | — | — | EP | claimed |
| WO-2022027020-A2 | ARTIFICIAL PLACENTA VACCINE FOR ORGAN TRANSPLANTATION | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2022-02-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589188-B2 | Hydrogels for in situ-forming tissue constructs | COL1A1, COL2A1, COL14A1 | NTSR1 2219/4885NTSR2 2455/4885NPY1R 290/4885 |
| US-12636476-B2 | Method of implantation of cell aggregates and tissue fragments | ILK, CD44, CAPG | NTSR1 2483/4885NTSR2 2156/4885NPY1R 3038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.